Halozyme Therapeutics
HALO
#1815
Rank
S$15.59 B
Marketcap
S$131.51
Share price
-0.41%
Change (1 day)
62.73%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): S$0.64 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.50 Billion. In 2025 the company made an earning of S$0.59 Billion a decrease over its 2024 earnings that were of S$0.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.64 B7.89%
2025 S$0.59 B-16.2%
2024 S$0.71 B59.94%
2023 S$0.44 B39.94%
2022 S$0.31 B0.16%
2021 S$0.31 B92.2%
2020 S$0.16 B-278.96%
2019 -S$92.53 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$78.89 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$41.28 Million-52.86%
2014 -S$87.57 Million-18.09%
2013 -S$0.11 Billion55.88%
2012 -S$68.59 Million169.94%
2011 -S$25.41 Million-63.44%
2010 -S$69.49 Million-7.19%
2009 -S$74.87 Million15.91%
2008 -S$64.59 Million83.89%
2007 -S$35.13 Million78.1%
2006 -S$19.73 Million16%
2005 -S$17.01 Million45.24%
2004 -S$11.71 Million682.42%
2003 -S$1.5 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.26 B 5,060.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.56 B 2,004.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85 B 6,083.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.80 B 1,421.43%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-S$0.66 Billion-200.92%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-S$36.6 Million-105.68%๐Ÿ‡บ๐Ÿ‡ธ USA